SlideShare a Scribd company logo
1 of 1
An Allelic Variant of mTOR Leads to Decreased DNA Damage
Response in Mouse Embryonic Fibroblasts
mTOR:
– Serine/threonine kinase involved in cell growth and survival
– Dysregulation of P13K/AKT/mTOR pathway observed in cancer
– Plasmacytoma susceptibility gene in BALB/c mice (Mock et al, Proc
Natl Acad Sci, 1993)
Zaw Phyo1,2, Joy Gary1,3, Nicholas Watson1, Shuling Zhan1, James Mitchell4, and Beverly Mock1
1- Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, 2- University of California, Los Angeles 3- Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine,
Michigan State University, 4-Radiation Biology Branch, CCR, NCI, NIH
Figure 1: mTOR Pathway
Allelic Variant and R628C KI Mouse
Goals
• Compare proliferation pattern of WT and KI primary MEFs post irradiation.
• Examine expression of proteins associated with the G1-S checkpoint
regulation in response to DNA damage.
Microarray
- 647 differentially expressed genes between WT and KI in bone marrow
- Ingenuity Pathway Analysis: DNA Replication, Recombination and
Repair determined as a significantly enriched network.
Figure 3:
(A) 628C KI mice (homozygous for the variant allele), heterozygotes and wild type mice
were treated once with lethal total body irradiation (TBI) dose of 8 Gy gamma radiation
and mouse survival was observed.
(B) WT and KI mice were exposed to fractionated doses of 1.75 Gy, once weekly for 4 weeks and
survival and thymic lymphoma formation was observed.
628C KI Mice have decreased survival post irradiation
Figure 2:
(A) In BALB/c mouse, a single-nucleotide polymorphism (SNP) is observed in exon 12 of
Mtor on chromosome 4, which leads to a single amino acid substitution at 628 in the
HEAT domain of the mTOR protein (R628C). 15 human cancer mutations found
within 100 amino acids of BALB/c variant.
(B) B6;129 mice undergo gene knock-in via homologous recombination to produce 628C
Knock-in mouse expressing the SNP (R628C KI)
(C)Polyphen-2 analysis of 1977T SNP and predicted the impact of the single amino acid
substitution to be deleterious to protein function.
Future Direction
• Utilize flow cytometry to detect cell cycle differences post irradiation
between WT and KI MEFs.
• Elucidate the role of p27kip1 in KI MEFs proliferation – examine if
overexpression of p27kip1 inhibit cell proliferation.
• Examine p27kip1 localization in WT and KI MEFs.
• Further understanding of mTOR’s downstream targets and binding partners
contribute to development of mTOR inhibiting drugs.
Acknowledgements
• Joy Gary and Nicholas Watson (Research Mentors)
• Beverly Mock (Principal Investigator) and the Mock Lab
• Laboratory of Cancer Biology & Genetics, National Cancer Institute
• Vi Black and the Cancer Research Internship (CRI) Program
• Sharon Milgram and the Office of Intramural Training & Education (OITE)
Conclusions
• 628C variant allele is associated with decreased survival upon treatment
with ionizing radiation.
• MEFs carrying the 628C allele may be more susceptible to DNA damage
and experience less DNA repair following ionizing radiation.
• KI MEFs proliferation at a higher rate than WT MEFs, irrespective of
radiation treatment.
• KI MEFs have lower levels of the cyclin dependent kinase inhibitor p27.
Introduction
Dancey, J. (2010) mTOR signaling and drug
development in cancer
Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.21
A
C
Homologous
recombination
B6;129 mouseBALB/c mouse
B
Irradiated Primary WT MEFs express higher levels of p-27kip1
Figure 6:
(A) Western blot analysis
suggests higher expression
of p-27kip1 in WT MEFs in
both untreated samples
and 30m, 1 hr, 3 hr and 6
hr post 2Gy irradiation.
(B) p27kip1 is a CDK inhibitor
essential in maintaining
cell cycle arrest. Its
degradation is mediated by
cdk2 or Akt pathway.
WT
p-27kip1
KI
2 Gy 4 Gy 2 Gy 4 Gy
α β tubulin
*
0
10
20
30
40
50
60
70
80
Unt 5 60 Unt 5 60
WT WT WT KI KI KI
AverageTailMoment
Minutes Post Irradiation
Average Tail Moment MEFs
*
*
* p=0.001
WT KI
** p<0.001
5 minutes 60 minutes
WT KI
**
**
628C KI Primary MEFs show greater DNA Damage post irradiation
Figure 4: Single Cell Gel Electrophoresis (SCGE) or Comet Assay Analysis of Primary
MEFs
(A) Representative comets of WT and KI MEFs at 5 mins and 60 mins post 4 Gy gamma
irradiation.
(B) Statistical analysis of tail moment from WT and KI MEFs at time points post-
irradiation. Time points with significantly different tail moments are marked with stars.
Error bars represent the standard error of the mean from 50 assessed comets for each
time point.
A
B
628C KI MEFs shows greater proliferation
Figure 5: Proliferation Assay of Primary MEFs
Proliferation of primary MEFs (2nd passage) were assessed post 2 Gy irradiation by
observing cell confluence every 6 hours in the InCucyte (Essen Biosience). Confluence
values represent the average of 45 wells and error bars represent standard error of the
mean. The assay was replicated with MEFs originating from different mice.
Cuadrado M, Gutierrez-Martinez P, Swat A, Nebreda AR, Fernandez-Capetillo O. p27kip1 stabilization is essential for the maintenance of cell cycle arrest in
response to DNA damage. Cancer research. 2009;69(22):8726-8732. doi:10.1158/0008-5472.CAN-09-0729.
Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1(4):193-9.
N=51
N=37
P=0.05

More Related Content

What's hot

IPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionIPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionSam Fess, MSc
 
Verifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaVerifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaCharlotte Broadbent
 
Cell cycle regulators
Cell cycle regulatorsCell cycle regulators
Cell cycle regulatorsishita1994
 
Van criekinge next_generation_epigenetic_profling_vvumc_uploaded
Van criekinge next_generation_epigenetic_profling_vvumc_uploadedVan criekinge next_generation_epigenetic_profling_vvumc_uploaded
Van criekinge next_generation_epigenetic_profling_vvumc_uploadedProf. Wim Van Criekinge
 
DNA methylation_ understanding the language of DNA 20130806
DNA methylation_ understanding the language of DNA 20130806DNA methylation_ understanding the language of DNA 20130806
DNA methylation_ understanding the language of DNA 20130806abizarl
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...Thermo Fisher Scientific
 
Ibica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylationIbica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylationAboul Ella Hassanien
 
Next-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones InfographicNext-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones InfographicQIAGEN
 
In search of tissue specific regulators in periodontium - a bioinformatic ap...
In search of tissue specific regulators in periodontium  - a bioinformatic ap...In search of tissue specific regulators in periodontium  - a bioinformatic ap...
In search of tissue specific regulators in periodontium - a bioinformatic ap...Agnieszka Caruso
 
Talk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meetTalk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meetProf Viyatprajna Acharya
 
SIP Poster - Sarah Sugarman
SIP Poster - Sarah SugarmanSIP Poster - Sarah Sugarman
SIP Poster - Sarah SugarmanSarah Sugarman
 
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Thermo Fisher Scientific
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationBrazilPharmaNews.com
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
 
Probes 2010
Probes 2010Probes 2010
Probes 2010toluene
 

What's hot (20)

IPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionIPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolution
 
Verifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic LeukemiaVerifying the role of AID in Chronic Lymphocytic Leukemia
Verifying the role of AID in Chronic Lymphocytic Leukemia
 
emboj200920a
emboj200920aemboj200920a
emboj200920a
 
Cell cycle regulators
Cell cycle regulatorsCell cycle regulators
Cell cycle regulators
 
Van criekinge next_generation_epigenetic_profling_vvumc_uploaded
Van criekinge next_generation_epigenetic_profling_vvumc_uploadedVan criekinge next_generation_epigenetic_profling_vvumc_uploaded
Van criekinge next_generation_epigenetic_profling_vvumc_uploaded
 
DNA methylation_ understanding the language of DNA 20130806
DNA methylation_ understanding the language of DNA 20130806DNA methylation_ understanding the language of DNA 20130806
DNA methylation_ understanding the language of DNA 20130806
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
 
Ibica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylationIbica2014 p(8) visualizing and identifying the dna methylation
Ibica2014 p(8) visualizing and identifying the dna methylation
 
publication 3
publication 3publication 3
publication 3
 
Microbiology:Oncogenes
Microbiology:Oncogenes Microbiology:Oncogenes
Microbiology:Oncogenes
 
Next-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones InfographicNext-Generation Sequencing Clinical Research Milestones Infographic
Next-Generation Sequencing Clinical Research Milestones Infographic
 
Mutants2
Mutants2Mutants2
Mutants2
 
In search of tissue specific regulators in periodontium - a bioinformatic ap...
In search of tissue specific regulators in periodontium  - a bioinformatic ap...In search of tissue specific regulators in periodontium  - a bioinformatic ap...
In search of tissue specific regulators in periodontium - a bioinformatic ap...
 
Talk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meetTalk on Cancer awareness on World cancer day-at JCI Talcher meet
Talk on Cancer awareness on World cancer day-at JCI Talcher meet
 
publication 1
publication 1publication 1
publication 1
 
SIP Poster - Sarah Sugarman
SIP Poster - Sarah SugarmanSIP Poster - Sarah Sugarman
SIP Poster - Sarah Sugarman
 
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
Assessment of TP53 Mutation Status in Breast Tumor Tissue using the "Ion Ampl...
 
Juliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology PresentationJuliane Carvalho Cancer Biology Presentation
Juliane Carvalho Cancer Biology Presentation
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discovery
 
Probes 2010
Probes 2010Probes 2010
Probes 2010
 

Similar to mTOR Variant Leads to Reduced DNA Damage Response

Antibody-Producing Cell Lines Development
Antibody-Producing Cell Lines DevelopmentAntibody-Producing Cell Lines Development
Antibody-Producing Cell Lines Developmentcreativebiogene1
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides coolesanum
 
Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...Agnieszka Caruso
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionDavid Andrews
 
Role of jak stat pathway in cancer signalling
Role of jak stat pathway in cancer signallingRole of jak stat pathway in cancer signalling
Role of jak stat pathway in cancer signallingJEYASREEG
 
Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapywarwick_amr
 
Molecular Genetics in MPN
Molecular Genetics in MPNMolecular Genetics in MPN
Molecular Genetics in MPNARUN KUMAR
 
Tumor suppression and inflammation: controlling the senescence associated se...
Tumor suppression and inflammation:  controlling the senescence associated se...Tumor suppression and inflammation:  controlling the senescence associated se...
Tumor suppression and inflammation: controlling the senescence associated se...adamfreund
 
BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalVictor Suarez
 
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus Yordan Penev
 
Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Neil Kubica
 
Aditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptxAditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptxArPratiwiHasanuddin1
 

Similar to mTOR Variant Leads to Reduced DNA Damage Response (20)

Antibody-Producing Cell Lines Development
Antibody-Producing Cell Lines DevelopmentAntibody-Producing Cell Lines Development
Antibody-Producing Cell Lines Development
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides
 
Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...Bioinformatic data analysis – comparison from three human studies using diffe...
Bioinformatic data analysis – comparison from three human studies using diffe...
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibition
 
Role of jak stat pathway in cancer signalling
Role of jak stat pathway in cancer signallingRole of jak stat pathway in cancer signalling
Role of jak stat pathway in cancer signalling
 
IACR 2016 poster
IACR 2016 posterIACR 2016 poster
IACR 2016 poster
 
Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapy
 
article
articlearticle
article
 
DISSO 4.1 (1)
DISSO 4.1 (1)DISSO 4.1 (1)
DISSO 4.1 (1)
 
Molecular Genetics in MPN
Molecular Genetics in MPNMolecular Genetics in MPN
Molecular Genetics in MPN
 
Tumor suppression and inflammation: controlling the senescence associated se...
Tumor suppression and inflammation:  controlling the senescence associated se...Tumor suppression and inflammation:  controlling the senescence associated se...
Tumor suppression and inflammation: controlling the senescence associated se...
 
Nicb Research Overview
Nicb Research OverviewNicb Research Overview
Nicb Research Overview
 
2013 SOT_NAMPT_CFU_poster
2013 SOT_NAMPT_CFU_poster2013 SOT_NAMPT_CFU_poster
2013 SOT_NAMPT_CFU_poster
 
BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_final
 
ijc 29918
ijc 29918ijc 29918
ijc 29918
 
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
In Vitro Characterization of a Novel Cis-acting Element (NCE) in the Cd4 Locus
 
Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810Ttp Lab Tech Talk 051810
Ttp Lab Tech Talk 051810
 
Utsw 2020 1
Utsw 2020 1Utsw 2020 1
Utsw 2020 1
 
CDAC 2018 Boeva discovery
CDAC 2018 Boeva discoveryCDAC 2018 Boeva discovery
CDAC 2018 Boeva discovery
 
Aditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptxAditya - Cell Cycle Article Presentation.pptx
Aditya - Cell Cycle Article Presentation.pptx
 

mTOR Variant Leads to Reduced DNA Damage Response

  • 1. An Allelic Variant of mTOR Leads to Decreased DNA Damage Response in Mouse Embryonic Fibroblasts mTOR: – Serine/threonine kinase involved in cell growth and survival – Dysregulation of P13K/AKT/mTOR pathway observed in cancer – Plasmacytoma susceptibility gene in BALB/c mice (Mock et al, Proc Natl Acad Sci, 1993) Zaw Phyo1,2, Joy Gary1,3, Nicholas Watson1, Shuling Zhan1, James Mitchell4, and Beverly Mock1 1- Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, 2- University of California, Los Angeles 3- Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, 4-Radiation Biology Branch, CCR, NCI, NIH Figure 1: mTOR Pathway Allelic Variant and R628C KI Mouse Goals • Compare proliferation pattern of WT and KI primary MEFs post irradiation. • Examine expression of proteins associated with the G1-S checkpoint regulation in response to DNA damage. Microarray - 647 differentially expressed genes between WT and KI in bone marrow - Ingenuity Pathway Analysis: DNA Replication, Recombination and Repair determined as a significantly enriched network. Figure 3: (A) 628C KI mice (homozygous for the variant allele), heterozygotes and wild type mice were treated once with lethal total body irradiation (TBI) dose of 8 Gy gamma radiation and mouse survival was observed. (B) WT and KI mice were exposed to fractionated doses of 1.75 Gy, once weekly for 4 weeks and survival and thymic lymphoma formation was observed. 628C KI Mice have decreased survival post irradiation Figure 2: (A) In BALB/c mouse, a single-nucleotide polymorphism (SNP) is observed in exon 12 of Mtor on chromosome 4, which leads to a single amino acid substitution at 628 in the HEAT domain of the mTOR protein (R628C). 15 human cancer mutations found within 100 amino acids of BALB/c variant. (B) B6;129 mice undergo gene knock-in via homologous recombination to produce 628C Knock-in mouse expressing the SNP (R628C KI) (C)Polyphen-2 analysis of 1977T SNP and predicted the impact of the single amino acid substitution to be deleterious to protein function. Future Direction • Utilize flow cytometry to detect cell cycle differences post irradiation between WT and KI MEFs. • Elucidate the role of p27kip1 in KI MEFs proliferation – examine if overexpression of p27kip1 inhibit cell proliferation. • Examine p27kip1 localization in WT and KI MEFs. • Further understanding of mTOR’s downstream targets and binding partners contribute to development of mTOR inhibiting drugs. Acknowledgements • Joy Gary and Nicholas Watson (Research Mentors) • Beverly Mock (Principal Investigator) and the Mock Lab • Laboratory of Cancer Biology & Genetics, National Cancer Institute • Vi Black and the Cancer Research Internship (CRI) Program • Sharon Milgram and the Office of Intramural Training & Education (OITE) Conclusions • 628C variant allele is associated with decreased survival upon treatment with ionizing radiation. • MEFs carrying the 628C allele may be more susceptible to DNA damage and experience less DNA repair following ionizing radiation. • KI MEFs proliferation at a higher rate than WT MEFs, irrespective of radiation treatment. • KI MEFs have lower levels of the cyclin dependent kinase inhibitor p27. Introduction Dancey, J. (2010) mTOR signaling and drug development in cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.21 A C Homologous recombination B6;129 mouseBALB/c mouse B Irradiated Primary WT MEFs express higher levels of p-27kip1 Figure 6: (A) Western blot analysis suggests higher expression of p-27kip1 in WT MEFs in both untreated samples and 30m, 1 hr, 3 hr and 6 hr post 2Gy irradiation. (B) p27kip1 is a CDK inhibitor essential in maintaining cell cycle arrest. Its degradation is mediated by cdk2 or Akt pathway. WT p-27kip1 KI 2 Gy 4 Gy 2 Gy 4 Gy α β tubulin * 0 10 20 30 40 50 60 70 80 Unt 5 60 Unt 5 60 WT WT WT KI KI KI AverageTailMoment Minutes Post Irradiation Average Tail Moment MEFs * * * p=0.001 WT KI ** p<0.001 5 minutes 60 minutes WT KI ** ** 628C KI Primary MEFs show greater DNA Damage post irradiation Figure 4: Single Cell Gel Electrophoresis (SCGE) or Comet Assay Analysis of Primary MEFs (A) Representative comets of WT and KI MEFs at 5 mins and 60 mins post 4 Gy gamma irradiation. (B) Statistical analysis of tail moment from WT and KI MEFs at time points post- irradiation. Time points with significantly different tail moments are marked with stars. Error bars represent the standard error of the mean from 50 assessed comets for each time point. A B 628C KI MEFs shows greater proliferation Figure 5: Proliferation Assay of Primary MEFs Proliferation of primary MEFs (2nd passage) were assessed post 2 Gy irradiation by observing cell confluence every 6 hours in the InCucyte (Essen Biosience). Confluence values represent the average of 45 wells and error bars represent standard error of the mean. The assay was replicated with MEFs originating from different mice. Cuadrado M, Gutierrez-Martinez P, Swat A, Nebreda AR, Fernandez-Capetillo O. p27kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage. Cancer research. 2009;69(22):8726-8732. doi:10.1158/0008-5472.CAN-09-0729. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999;1(4):193-9. N=51 N=37 P=0.05